Fibromuscular dysplasia epidemiology and demographics
Fibromuscular dysplasia Microchapters |
Diagnosis |
---|
Treatment |
ASA/ACCF/AHA Guideline Recommendations |
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
Case Studies |
Fibromuscular dysplasia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Fibromuscular dysplasia epidemiology and demographics |
FDA on Fibromuscular dysplasia epidemiology and demographics |
CDC on Fibromuscular dysplasia epidemiology and demographics |
Fibromuscular dysplasia epidemiology and demographics in the news |
Blogs on Fibromuscular dysplasia epidemiology and demographics |
Risk calculators and risk factors for Fibromuscular dysplasia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Prevalence
- The prevalence of FMD in the general population is not known; however the prevalence of renal artery FMD has been estimated to be as high as 4 per 100 adults.
- In one of the largest series of >1000 patients with FMD, 58% had involvement the renal artery, 32% involved the
extracranial cerebrovascular arteries and 10% involved other arterial territories such as the iliac artery or intracranial vessels. Approximately two-thirds of patients have multiple arteries involved
Age
- Patients of all age groups may develop FMD.
- The mean age at diagnosis of the first 447 patients enrolled in the U.S. Registry for FMD was 51.9 ± 13.1 years (range of 5 to 86 years),
Gender
- Women are more commonly affected by FMD than men. The women to men ratio is approximately 9:1.5.
- In the US Registry, 91%of registrants were female.